![](http://www.data-institute.org/BASE_FOLDERS/images/chem-pharma2.png)
|
This Zolpidem World Consumption Report provides data on the net consumption
of Zolpidem Pharmaceuticals in each of the
countries listed. The Pharmaceuticals covered (Zolpidem) are classified by the
Chemical Registry, EC, EU, CAS, or other coding system.
In addition, where available this consumption is further analysed by
Application or End User sector.
|
The Zolpidem World Consumption Report gives 6 pages
of data for each of over 200 countries plus thousands of database tables
and spreadsheets. The Pharmaceutical World Consumption Reports cost
£2950. Online delivery 24 hours. This report specifications: All Zolpidem (CR_307762) Products covered, over 200 Countries covered, 2042 pages, 5631 spreadsheets, 5765 database tables, 503 diagrams & maps. Contents change for each edition.
This report consists of a download Zipped file
(300-1200MB), plus a DVD,
containing the entire report web and databases. The data is supplied as Open Source and readers can access, and are free to reproduce, the information for inclusion into their own documents or
reports. The tables & databases are in Access & Excel formats
which enable readers to produce their own spreadsheet calculations
and modeling. There are five additional DVDs available which provide
Ancillary Data, Tools, and Utilities for the analysis and handling of
the databases. This database is updated monthly. After-Sales and update
services available from The Data Institute.
|
![](http://www.data-institute.org/BASE_FOLDERS/images/chem-pharma2.png)
The measure of Zolpidem Consumption is given at industry level
and/or wholesale level when supplied by distributors.
|
|
The Zolpidem World Consumption
Report has the following contents:
|
The Zolpidem World Consumption Report Chapters:
|
|
The Zolpidem World Consumption Report gives
data for Each country for Zolpidem :
|
The Zolpidem World Consumption Report covers most of these countries:
In some countries certain Pharmaceutical
products are not consumed for various reasons. Where the Pharmaceutical is not consumed there will be no data for that
particular country.
The countries marked * indicate a
data caveat due to local survey conditions. |
|
|
![](http://www.data-institute.org/BASE_FOLDERS/images/chem-pharma2.png)
|
TIME SERIES ![Historic Time Series](http://www.data-institute.org/BASE_FOLDERS/images/graph.gif)
The report provides data for each year of three time
series: |
Historic data is given from 1997 to Current Year
Current time series data is given Current Year to 2018
Long Term Projection is given from 2018 to 2028
|
|
|
1.
RELATIVE CONSUMPTION
in US$ (Purchasing Parity Index applied)
by Country by Chemical Registry Number by Year (3 series)
since 1997 to Current Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
Index of Consumption by Year by Chemical Registry Number
Value of Consumption by Year by Chemical Registry Number
Year-on-Year Growth Rates by Chemical Registry Number |
|
|
2.
LOCAL CONSUMPTION
in Local Currency (Relative Inflation Index applied)
by Country by Chemical Registry Number by Year
since 1997 to Current Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
Index of Consumption by Year by Chemical Registry Number
Value of Consumption by Year by Chemical Registry Number
Year-on-Year Growth Rates by Chemical Registry Number |
|
|
3.
PER-CAPITA CONSUMPTION
in US$
by Country by Chemical Registry Number by Year
since 1997 to Current Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
Index of Consumption by Year by Chemical Registry Number
Value of Consumption by Year by Chemical Registry Number
Year-on-Year Growth Rates by Chemical Registry Number |
|
|
4.
PRODUCT MARKETING COSTS & MARGINS
given as a percentage of Sales
by Country by Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
|
|
|
|
|
|
|
5.
PRODUCT LAUNCH DATA
by Country by Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
New Product Adoption Rate
New Product Conversion Rates
New Product First Sales Growth Rates
Product Revisions Adoption Rate
Product Revisions Conversion Rates
Product Revisions Sales Growth Rates |
|
|
6.
IMMEDIATE BUYERS & END USERS
CUSTOMER BASE PROFILE
by Country by Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
% of TOTAL
REVENUE accounted for by:
Manufacturers & OEM buyers
Wholesale establishments
Government
Retail outlets
other immediate customers |
|
|
7.
IMMEDIATE BUYERS & END USERS
CONSUMER DEMOGRAPHICS
by Country by Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
% of TOTAL BUYERS:
The data is given as a series or matrix of Age Group and
Social Group:
|
|
|
|
|
|
8.
HISTORIC INDUSTRY BALANCE SHEET DATA
by Country
to
Current Year
|
9. FORECAST INDUSTRY FINANCIAL DATA
by Country by Year
Medium Term Forecast
Current Year to 2018
Long Term Forecast 2018 to 2028 |
|
Historic & Forecast Financial Data covered:-
|
|
|
|
|
|
|
10.
INDUSTRY PROFILE
INDUSTRY NORMS
Norms for the Product industry are
shown in this section. This represents the major industry sector data for
the industry and as such forms the basis of comparison.
Only the most critical factors should be
compared with the various scenarios given above as industry averages can at best
represent an indication and not a specific point of measure.
Reliance on Industry Norms are often used
by analysts in order to support theories and suppositions and these are in turn
used for investment scenarios. In fact Industry Norms or Averages are not
tangible as they combine and manipulate data from companies in wide ranging
activities and thus much of the data is superficial.
Much of the benefit in the analysis of
Industry Norms is to use the data to provide guide-lines or parameters which can
be seen to define and identify the target industry sector.
|
|
|
|
|
|
|
|
|